Publications by authors named "F Mozzani"

Objectives: The revised Fibromyalgia Impact Questionnaire (FIQR) is a widely used fibromyalgia severity assessment tool that was introduced in 2009 prior to the publication of the American College of Rheumatology (ACR) preliminary fibromyalgia criteria in 2010 and its revision in 2016. In 2020, the modified Fibromyalgia Assessment Scale (FASmod) was published. The Polysymptomatic Distress scale (PSD) of the fibromyalgia criteria and FASmod include assessments of pain location severity and can be used for diagnosis as well as in non-fibromyalgia patients.

View Article and Find Full Text PDF

Objective: There are few real-world setting studies focused on apremilast effectiveness (i.e., retention rate) in psoriatic arthritis (PsA).

View Article and Find Full Text PDF

Objectives: Fibromyalgia (FM) is a chronic musculoskeletal pain syndrome of unknown aetiopathogenesis. Its development and maintenance are related to the interplay of biological, psychological, and contextual factors. Among the contextual factors, sociodemographic aspects are poorly elucidated.

View Article and Find Full Text PDF

Objectives: The role of age in influencing the severity of fibromyalgia (FM) is still controversial. The aim of this study is to define the contribution of age in the severity of FM from data from a large national database.

Methods: This cross-sectional study included adult patients with FM diagnosed according to the 2010/2011 American College of Rheumatology criteria.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the clinical outcomes of patients with autoimmune arthritis receiving either the original adalimumab or its biosimilar, ABP 501, and analyzes data from treatments provided between January 2003 and December 2020.
  • - A total of 1,046 patients were categorized into three groups: those naive to the original adalimumab (oADA), those naive to ABP 501 (bADA), and those who switched from oADA to ABP 501 (sADA).
  • - The 18-month retention rates for the three groups were similar, with slight variations: 81.5% for oADA, 84.0% for bADA, and 88.0
View Article and Find Full Text PDF